AMGEN Competition

Bonds . USA . 
Bond . AMGEN INC
031162CR9   73.61  4.07  5.24%   
  
Hype
Prediction
LowEstimatedHigh
72.6873.6174.54
Details
Intrinsic
Valuation
LowRealHigh
69.0569.9880.97
Details
Naive
Forecast
LowNextHigh
71.2772.2073.13
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
73.5576.2178.88
Details

AMGEN Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between AMGEN and its competitors represents the degree of relationship between the price movements of corresponding bonds. A correlation of about +1.0 implies that the price of AMGEN and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of AMGEN INC does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
PYPL
+ 0.89
FUND
IONQ
+ 0.87
FUND
PYPL
+ 0.86
IONQ
IONQ
+ 0.82
BBAI
GOOG
+ 0.79
FUND
PYPL
+ 0.79
GOOG
  
High negative correlations   
BBAI
- 0.57
90331HPL1
RXRX
- 0.48
90331HPL1
FUND
- 0.45
90331HPL1
IONQ
- 0.41
90331HPL1
APLD
- 0.39
90331HPL1
INMD
- 0.3
90331HPL1

Risk-Adjusted Indicators

There is a big difference between AMGEN Bond performing well and AMGEN Corporate Bond doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AMGEN's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
00108WAF7  1.33  0.18  0.00 (0.24) 1.84 
(1.41)
 3.24 
(2.55)
 10.75 
90331HPL1  0.37  0.02  0.00  0.06  0.00 
 0.00 
 1.39 
(1.70)
 7.07 
APLD  5.24  0.40  0.10  0.29  5.09 
(5.88)
 10.56 
(8.40)
 28.97 
BBAI  5.11  1.41  0.23  9.84  4.53 
(6.51)
 17.05 
(7.85)
 36.41 
INMD  2.12  0.06  0.06  0.14  2.73 
(2.18)
 4.56 
(5.21)
 17.38 
FUND  0.57  0.05  0.03  0.19  0.44 
(0.66)
 1.30 
(1.02)
 4.46 
IONQ  6.03  2.47  0.43  1.11  4.81 
(7.26)
 16.30 
(9.99)
 47.83 
GOOG  1.10  0.28  0.13  0.71  1.23 
(1.14)
 2.22 
(1.95)
 8.60 
PYPL  1.35  0.25  0.17  0.32  1.25 
(1.52)
 3.52 
(2.59)
 10.05 
RXRX  3.70  0.24  0.06  0.27  4.57 
(3.81)
 8.32 
(6.56)
 20.99 
All Fundamental Data

AMGEN Competitive Analysis

The better you understand AMGEN competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, AMGEN's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across AMGEN's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
031162CR9 00108WAF7 90331HPL1 APLD BBAI INMD FUND IONQ GOOG PYPL
 5.24 
 73.61 
AMGEN
 8.19 
 82.21 
00108WAF7
 2.15 
 97.53 
90331HPL1
 5.25 
 9.02 
Applied
 15.03 
 3.11 
BigBearai
 1.49 
 18.56 
InMode
 0.49 
 8.16 
Sprott
 3.71 
 32.97 
IONQ
 5.32 
 186.53 
Alphabet
 1.38 
 88.76 
PayPal
Market Volatility
(90 Days Market Risk)
Very steady
Out of control
Very steady
Moderately volatile
Dangerous
Not too volatile
Very steady
Slightly risky
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
OK
Very Weak
OK
Good
Modest
Solid
Solid
Solid
Solid
Odds of Financial Distress
(Probability Of Bankruptcy)
Below Average
Below Average
Below Average
Below Average
Below Average
Low
Low
Below Average
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Under Valued
Over Valued
Under Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Strong Buy
Buy
Buy
Strong Sell
Buy
Strong Buy
Buy
Trade Advice
(90 Days Macroaxis Advice)
Sell
Strong Sell
Strong Sell
Sell
Strong Sell
Strong Sell
Strong Buy
Cautious Hold
Strong Buy
Strong Buy
Current Ratio
N/A
N/A
N/A
0.87
2.35
9.74
4.04
30.11
2.52
1.27
Net Asset
N/A
N/A
N/A
762.87 M
199.91 M
863.29 M
266.3 M
553.58 M
402.39 B
82.17 B
Profit Margin
N/A
N/A
N/A
-0.75
-1.1
0.36
3.27
N/A
0.28
0.14
EBITDA
N/A
N/A
N/A
(43.38 M)
(37.57 M)
196.28 M
27.54 M
(147.38 M)
97.97 B
6.83 B
Operating Margin
N/A
N/A
N/A
-0.24
-0.2
0.37
0.67
-4.29
0.32
0.18
Current Valuation
N/A
N/A
N/A
2.62 B
987.54 M
756.96 M
242.2 M
7.93 B
2.09 T
88.17 B
Price To Book
N/A
N/A
N/A
9.32
8.6
1.95
0.95
18.86
6.9
4.47
Retained Earnings
N/A
N/A
N/A
(249.99 M)
(313.43 M)
693.43 M
72.6 M
(352.07 M)
211.25 B
23.2 B
Current Asset
N/A
N/A
N/A
1.68 M
N/A
75.11 M
N/A
N/A
105.41 B
20.65 B
Five Year Return
N/A
N/A
N/A
N/A
N/A
N/A
8.05
N/A
N/A
N/A
Beta
N/A
N/A
N/A
4.52
3.18
2.15
1.06
1.89
1.03
1.44
Number Of Employees
N/A
N/A
N/A
150
480
581
N/A
324
181.27 K
27.2 K
Shares Outstanding
N/A
N/A
N/A
211.25 M
250.59 M
76.25 M
29.81 M
216.39 M
5.53 B
1 B
Cash Flow From Operations
N/A
N/A
N/A
13.79 M
(18.31 M)
176.83 M
N/A
(78.81 M)
101.75 B
4.84 B
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
0.0747
N/A
0.0043
N/A
Total Debt
N/A
N/A
N/A
427.81 M
200.59 M
9.02 M
386.47 K
8.11 M
28.5 B
9.68 B
Return On Equity
N/A
N/A
N/A
-0.67
-7.38
0.21
0.11
-0.37
0.32
0.22
Return On Asset
N/A
N/A
N/A
-0.0883
-0.0913
0.11
0.0131
-0.25
0.16
0.0434
Number Of Shares Shorted
N/A
N/A
N/A
39.29 M
20.19 M
6.44 M
25.45 K
38.02 M
43.49 M
22.84 M
Book Value Per Share
N/A
N/A
N/A
1.54
0.39
9.57
8.54
2.02
25.61
20.05
Current Liabilities
N/A
N/A
N/A
2.02 M
N/A
55.5 M
N/A
N/A
16.76 B
13.62 B
Total Asset
N/A
N/A
N/A
762.87 M
199.91 M
863.29 M
266.3 M
553.58 M
402.39 B
82.17 B
Debt To Equity
N/A
N/A
N/A
0.28
N/A
0.007
9.5
0.007
0.12
0.56
Short Ratio
N/A
N/A
N/A
2.92
3.66
5.35
0.43
1.34
2.03
2.12
Target Price
N/A
N/A
N/A
11.14
2.63
21.33
N/A
18.58
206.69
91.66
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
N/A
0.5
N/A
0.4
N/A
Shares Owned By Institutions
N/A
N/A
N/A
65.46
9.93
64.2
62.72
36.89
61.46
74.97
Market Capitalization
N/A
N/A
N/A
2.01 B
917.14 M
1.44 B
242.02 M
7.41 B
2.16 T
90.23 B
Price To Earning
N/A
N/A
N/A
-0.03
N/A
20.78
18.81
N/A
20.62
40.65
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
2.9
N/A
-1.01
1.11
1.52
Price To Sales
N/A
N/A
N/A
10.59
5.92
3.39
28.82
197.74
6.34
2.87
Net Income
N/A
N/A
N/A
(149.27 M)
(60.37 M)
197.92 M
27.48 M
(157.77 M)
73.8 B
4.25 B
Earnings Per Share
N/A
N/A
N/A
-1.23
-0.78
1.83
0.56
-0.82
7.54
4.18
Shares Owned By Insiders
N/A
N/A
N/A
20.76
49.24
10.75
52.28
9.83
0.022
0.22
Revenue
N/A
N/A
N/A
165.57 M
155.16 M
492.05 M
27.85 M
22.04 M
307.39 B
29.77 B
Working Capital
N/A
N/A
N/A
(355.27 M)
(4.84 M)
781.19 M
N/A
352.82 M
89.72 B
14.1 B
Cash And Equivalents
N/A
N/A
N/A
40.83 M
29.83 M
486.39 M
76.77 K
423.35 M
116.26 B
10.85 B
Cash Per Share
N/A
N/A
N/A
0.44
0.24
5.91
N/A
2.12
8.98
9.52
Gross Profit
N/A
N/A
N/A
(957 K)
42.99 M
380.79 M
6.79 M
1.1 M
156.63 B
11.65 B
Day Typical Price
73.61
82.21
97.53
9.26
3.23
18.6
8.14
34.12
185.74
89.05
Accumulation Distribution
N/A
N/A
N/A
493743.0
7.7 M
12638.94
89.83
2.8 M
977019.0
120364.0
Daily Balance Of Power
(9,223,372,036,855)
9.2 T
(9,223,372,036,855)
(0.65)
(1.04)
(0.52)
0.8
(0.31)
1.759328
(0.77)
Period Momentum Indicator
(4.07)
6.22
(2.14)
(0.50)
(0.55)
(0.28)
0.04
(1.27)
9.43
(1.24)
Rate Of Daily Change
0.95
1.08
0.98
0.95
0.85
0.99
1.0
0.96
1.05
0.99
Day Median Price
73.61
82.21
97.53
9.39
3.3
18.62
8.14
34.69
185.35
89.19
Price Action Indicator
(2.04)
3.11
(1.07)
(0.62)
(0.46)
(0.20)
0.045
(2.36)
5.9
(1.05)
Coefficient Of Variation
(767.74)
1643.48
(10,093)
935.58
509.27
948.95
531.68
293.0
437.2
464.4
Mean Deviation
0.6375
1.33
0.371
5.24
5.11
2.12
0.5694
6.03
1.1
1.35
Jensen Alpha
(0.13)
0.1796
0.02
0.3995
1.41
0.0572
0.0537
2.47
0.2843
0.2461
Total Risk Alpha
(0.28)
(0.22)
(0.17)
(0.33)
0.2666
(0.17)
0.0129
1.47
0.0971
0.0932
Sortino Ratio
N/A
0.0032
N/A
0.0992
0.2294
0.0608
0.0284
0.4259
0.134
0.1669
Downside Variance
N/A
4.16
N/A
30.04
32.5
9.86
0.5228
38.5
2.8
2.55
Standard Deviation
0.9237
2.15
0.9358
6.25
7.29
2.99
0.771
8.11
1.52
1.81
Kurtosis
4.2
6.06
9.84
(0.48)
2.55
1.84
2.7
2.64
2.18
1.4
Potential Upside
0.905
3.24
1.39
10.56
17.05
4.56
1.3
16.3
2.22
3.52
Treynor Ratio
(86.88)
(0.24)
0.0561
0.2911
9.84
0.1408
0.1899
1.11
0.714
0.3237
Maximum Drawdown
6.46
10.75
7.07
28.97
36.41
17.38
4.46
47.83
8.6
10.05
Variance
0.8532
4.63
0.8757
39.1
53.18
8.97
0.5944
65.72
2.32
3.29
Market Risk Adjusted Performance
(86.87)
(0.23)
0.0661
0.3011
9.85
0.1508
0.1999
1.12
0.724
0.3337
Risk Adjusted Performance
(0.09)
0.0506
(0)
0.0861
0.1508
0.0837
0.1365
0.2556
0.1705
0.1616
Skewness
(0.50)
0.7045
(0.87)
0.3397
1.09
(0.05)
0.8621
0.9023
0.0125
0.4773
Semi Deviation
N/A
1.84
N/A
5.09
4.53
2.73
0.4376
4.81
1.23
1.25
Information Ratio
(0.26)
0.003
(0.14)
0.087
0.1793
0.0638
0.0267
0.326
0.1471
0.1467
Value At Risk
(1.58)
(2.55)
(1.70)
(8.40)
(7.85)
(5.21)
(1.02)
(9.99)
(1.95)
(2.59)
Expected Short fall
N/A
(1.41)
N/A
(5.88)
(6.51)
(2.18)
(0.66)
(7.26)
(1.14)
(1.52)
Downside Deviation
N/A
2.04
N/A
5.48
5.7
3.14
0.723
6.21
1.67
1.6
Semi Variance
N/A
3.39
N/A
25.93
20.49
7.45
0.1915
23.18
1.52
1.55

AMGEN Competition Performance Charts

Five steps to successful analysis of AMGEN Competition

AMGEN's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by AMGEN INC in relation to its competition. AMGEN's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of AMGEN in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact AMGEN's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to AMGEN INC, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your AMGEN position

In addition to having AMGEN in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Iron Thematic Idea Now

Iron
Iron Theme
Companies involved in production of steel and iron. The Iron theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Iron Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in AMGEN Bond

AMGEN financial ratios help investors to determine whether AMGEN Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AMGEN with respect to the benefits of owning AMGEN security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY